Display options
Cite
Williams MT, Davis AK, Xin Y, et al. People of color in North America report improvements in racial trauma and mental health symptoms following psychedelic experiences. Drugs (Abingdon Engl). 2020;28(3):215-226doi: 10.1080/09687637.2020.1854688.
Williams, M. T., Davis, A. K., Xin, Y., Sepeda, N. D., Grigas, P. C., Sinnott, S., & Haeny, A. M. (2021). People of color in North America report improvements in racial trauma and mental health symptoms following psychedelic experiences. Drugs (Abingdon, England), 28(3), 215-226. https://doi.org/10.1080/09687637.2020.1854688
Williams, Monnica T, et al. "People of color in North America report improvements in racial trauma and mental health symptoms following psychedelic experiences." Drugs (Abingdon, England) vol. 28,3 (2021): 215-226. doi: https://doi.org/10.1080/09687637.2020.1854688
Williams MT, Davis AK, Xin Y, Sepeda ND, Grigas PC, Sinnott S, Haeny AM. People of color in North America report improvements in racial trauma and mental health symptoms following psychedelic experiences. Drugs (Abingdon Engl). 2021;28(3):215-226. doi: 10.1080/09687637.2020.1854688. Epub 2020 Dec 10. PMID: 34349358; PMCID: PMC8330400.
Copy Download .nbib Format: NLM
Share it on

Drugs (Abingdon Engl). 2021;28(3):215-226. doi: 10.1080/09687637.2020.1854688. Epub 2020 Dec 10.

People of color in North America report improvements in racial trauma and mental health symptoms following psychedelic experiences.

Drugs (Abingdon, England)

Monnica T Williams, Alan K Davis, Yitong Xin, Nathan D Sepeda, Pamela Colόn Grigas, Sinead Sinnott, Angela M Haeny

Affiliations

  1. School of Psychology, University of Ottawa, Ottawa, Canada.
  2. Department of Psychological Sciences, University of Connecticut, Storrs, CT, USA.
  3. College of Social Work, The Ohio State University, Columbus, OH, USA.
  4. Center for Psychedelic and Consciousness Research, Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD, USA.
  5. Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.

PMID: 34349358 PMCID: PMC8330400 DOI: 10.1080/09687637.2020.1854688

Abstract

This study examined how psychedelics reduced symptoms of racial trauma among black, indigenous, and people of color (BIPOC) subsequent to an experience of racism. A cross-sectional internet-based survey included questions about experiences with racism, mental health symptoms, and acute and enduring psychedelic effects. Changes in mental health were assessed by retrospective report of symptoms in the 30 days before and 30 days after an experience with psilocybin, Lysergic acid diethylamide (LSD), or 3,4-Methylenedioxymethamphetamine (MDMA). We recruited 313 diverse BIPOC in the US and Canada. Results revealed a significant (

Keywords: Psychedelics; ethnic minorities; hallucinogens; people of color; racial trauma; substance use

References

  1. Front Pharmacol. 2018 Jan 17;8:974 - PubMed
  2. Psychol Bull. 2009 Jul;135(4):531-54 - PubMed
  3. Am J Drug Alcohol Abuse. 2019;45(2):161-169 - PubMed
  4. BMC Psychiatry. 2018 Jul 31;18(1):245 - PubMed
  5. Neurotherapeutics. 2017 Jul;14(3):734-740 - PubMed
  6. Psychol Health. 2018 Feb;33(2):193-212 - PubMed
  7. Psychol Addict Behav. 2012 Sep;26(3):550-60 - PubMed
  8. Perspect Psychol Sci. 2020 Jan;15(1):38-43 - PubMed
  9. West J Nurs Res. 2015 Jun;37(6):812-30 - PubMed
  10. J Psychopharmacol. 2018 Dec;32(12):1385-1391 - PubMed
  11. Perspect Psychol Sci. 2020 Jan;15(1):3-26 - PubMed
  12. J Racial Ethn Health Disparities. 2015 Mar;2(1):34-42 - PubMed
  13. JAMA Psychiatry. 2021 May 1;78(5):481-489 - PubMed
  14. J Psychopharmacol. 2016 Dec;30(12):1181-1197 - PubMed
  15. J Am Acad Psychiatry Law. 2002;30(3):336-9 - PubMed
  16. J Health Soc Behav. 2003 Sep;44(3):426-41 - PubMed
  17. Lancet. 2018 Jul 28;392(10144):302-310 - PubMed
  18. Behav Sci (Basel). 2014 May 14;4(2):102-24 - PubMed
  19. J Psychopharmacol. 2021 Apr;35(4):437-446 - PubMed
  20. Am Psychol. 2007 May-Jun;62(4):271-86 - PubMed
  21. Sci Rep. 2020 Feb 10;10(1):2214 - PubMed
  22. Psychopharmacology (Berl). 2011 Dec;218(4):649-65 - PubMed
  23. J Psychopharmacol. 2015 Mar;29(3):270-9 - PubMed
  24. J Psychopharmacol. 2018 Dec;32(12):1295-1307 - PubMed
  25. J Contextual Behav Sci. 2020 Jan;15:39-45 - PubMed
  26. J Health Soc Behav. 2006 Dec;47(4):373-89 - PubMed
  27. J Consult Clin Psychol. 1991 Oct;59(5):715-23 - PubMed
  28. J Clin Psychopharmacol. 2016 Feb;36(1):77-81 - PubMed
  29. Lancet Psychiatry. 2018 Jun;5(6):486-497 - PubMed
  30. Addict Behav. 2019 Feb;89:35-43 - PubMed
  31. J Psychopharmacol. 2015 Nov;29(11):1182-90 - PubMed
  32. Adolescence. 2006 Spring;41(161):1-14 - PubMed
  33. Clin Psychol Rev. 2010 Aug;30(6):635-41 - PubMed
  34. J Behav Med. 2006 Feb;29(1):79-94 - PubMed
  35. Cogn Behav Ther. 2019 Jan;48(1):1-14 - PubMed
  36. CNS Spectr. 2009 Jan;14(1 Suppl 1):32-43 - PubMed
  37. PLoS One. 2019 Apr 23;14(4):e0214377 - PubMed
  38. Lancet Psychiatry. 2016 Jul;3(7):619-27 - PubMed
  39. Behav Brain Sci. 2015;38:e1 - PubMed
  40. Addict Behav. 2015 Jan;40:119-25 - PubMed
  41. Soc Sci Med. 2013 Oct;95:115-27 - PubMed
  42. J Pers Soc Psychol. 2008 Oct;95(4):918-32 - PubMed
  43. Dev Psychol. 2014 Jul;50(7):1910-8 - PubMed
  44. J Anxiety Disord. 2011 Mar;25(2):258-65 - PubMed
  45. J Consult Clin Psychol. 2010 Aug;78(4):480-9 - PubMed
  46. Anxiety Stress Coping. 2007 Sep;20(3):253-65 - PubMed
  47. Am Psychol. 2019 Jan;74(1):20-35 - PubMed
  48. J Psychopharmacol. 2016 Dec;30(12):1165-1180 - PubMed
  49. Am Psychol. 2019 Jan;74(1):143-155 - PubMed
  50. J Pers Assess. 2005 Feb;84(1):37-48 - PubMed
  51. Psychiatry. 2008 Summer;71(2):134-68 - PubMed
  52. Behav Res Methods. 2014 Mar;46(1):112-30 - PubMed
  53. J Psychopharmacol. 2016 Dec;30(12):1279-1295 - PubMed
  54. Addiction. 2019 Jun;114(6):957-967 - PubMed
  55. Suicide Life Threat Behav. 2015 Oct;45(5):567-576 - PubMed
  56. J Psychopharmacol. 2011 Nov;25(11):1453-61 - PubMed
  57. Am J Public Health. 2008 Sep;98(9 Suppl):S176-80 - PubMed
  58. J Psychopharmacol. 2016 Jul;30(7):595-600 - PubMed
  59. J Youth Adolesc. 2012 Jul;41(7):831-46 - PubMed

Publication Types

Grant support